Clinical Trial Update: Asciminib Roll-over Study [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 roll-over study of asciminib for chronic myeloid leukemia that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Phase 4 | Status: RECRUITING